Jill M Ricono

Title: Jill M Ricono: Innovator in Cancer Treatment

Introduction

Jill M Ricono is a prominent inventor based in Encinitas, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic agents. With a focus on SHP2 inhibitors, her work aims to improve treatment options for patients battling solid tumors.

Latest Patents

Jill M Ricono holds 2 patents that highlight her groundbreaking work. Her latest patents include "SHP2 inhibitor monotherapy and uses thereof," which provides SHP2 inhibitors for use in the reduction of solid tumors in a method of treating cancer. Additionally, she has developed "Combination therapies comprising SHP2 inhibitors and PD-1 inhibitors," which outlines combinations that include a SHP2 inhibitor and a PD-1 inhibitor for effective cancer treatment.

Career Highlights

Ricono's career is marked by her dedication to advancing cancer therapies. She is currently associated with Huyabio International, LLC, where she continues to innovate and contribute to the field. Her research has the potential to change the landscape of cancer treatment, offering new hope to patients.

Collaborations

Throughout her career, Jill has collaborated with notable professionals in her field, including Farbod Shojaei and Robert Goodenow. These collaborations have further enhanced her research and development efforts, leading to significant advancements in cancer therapies.

Conclusion

Jill M Ricono is a trailblazer in the field of cancer treatment, with her innovative patents and collaborative efforts paving the way for new therapeutic options. Her work exemplifies the impact of dedicated research on improving patient outcomes in oncology.